CAREDX INC. - COMMON STOCK

CareDx Enrolls First Patients in the Largest Digital Study in Transplant Using AlloCare to Assess Patient Outcomes

18 Nov 2021 06:00:00 By Nasdaq GlobeNewswire

CareDx To Participate in Upcoming Conferences

15 Nov 2021 15:05:00 By Nasdaq GlobeNewswire

CareDx Acquires MedActionPlan to Directly Support Patients with Better Adherence

10 Nov 2021 06:00:03 By Nasdaq GlobeNewswire

University of Alabama Integrates CareDx’s TxAccess for Connection to Over 500 Community Practices

04 Nov 2021 06:00:01 By Nasdaq GlobeNewswire

CareDx Focuses on Innovation in Transplant at ASN Kidney Week

03 Nov 2021 06:00:02 By Nasdaq GlobeNewswire

CareDx Completes Orderly Management Transition

01 Nov 2021 15:01:00 By Nasdaq GlobeNewswire

CareDx Reports Third Quarter 2021 Results; Increases Full Year Revenue Guidance

28 Oct 2021 15:01:00 By Nasdaq GlobeNewswire

CareDx’s AlloSure Demonstrates Better Accuracy Than Current Standards of Care in Independent Kidney Transplant Study

21 Oct 2021 06:00:01 By Nasdaq GlobeNewswire

CareDx and Eledon Pharmaceuticals Announce Collaborative Research Agreement

19 Oct 2021 06:00:01 By Nasdaq GlobeNewswire

CareDx to Report Third Quarter 2021 Financial Results

14 Oct 2021 15:01:00 By Nasdaq GlobeNewswire

AlloSure, the First dd-cfDNA in Heart and Kidney Transplantation, Launches for Lung Transplant Patients

12 Oct 2021 09:18:53 By Nasdaq GlobeNewswire

CareDx Extends Leadership in Multimodality Transplant Care with KidneyCare Validation Publication

30 Sep 2021 15:01:00 By Nasdaq GlobeNewswire

CareDx Continues to Fight for Innovation in Transplantation

28 Sep 2021 18:18:01 By Nasdaq GlobeNewswire

CareDx Presents Latest Data on AlloSeq Portfolio at ASHI 2021

27 Sep 2021 06:00:00 By Nasdaq GlobeNewswire

CareDx Names Longtime Patient Advocate Art Torres to Board of Directors

15 Sep 2021 07:00:00 By Nasdaq GlobeNewswire

CareDx to Participate in Upcoming Conferences

02 Sep 2021 06:00:01 By Nasdaq GlobeNewswire

CareDx Showcases Leadership in Global Transplantation at ESOT 2021

26 Aug 2021 06:00:01 By Nasdaq GlobeNewswire

CareDx Reports 77% Revenue Growth for Second Quarter of 2021 and Increases Full Year Revenue Guidance

29 Jul 2021 15:01:00 By Nasdaq GlobeNewswire

CareDx Launches ACROBAT Study to Potentially Change Care Paradigm for Stem Cell Transplant Patients

26 Jul 2021 06:00:00 By Nasdaq GlobeNewswire

CareDx to Report Second Quarter 2021 Financial Results

15 Jul 2021 06:00:00 By Nasdaq GlobeNewswire